STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
82 hedge funds and large institutions have $310M invested in Stemline Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+2
Holders Change %
+2.5%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
31
Reduced
18
Closed
13
Calls
$296K
Puts
$2.15M
Net Calls
-$1.85M
Net Calls Change
-$2.51M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$48.2M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$8.95M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$13.7M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$8.02M |
| 5 |
NC
5
Nexthera Capital
New York
|
$8.01M |
